- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Collaborators
- Suppliers
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- Research centres
- People
- Alistair Brown
- Anne-Laure Puaux
- Assoc Prof Joanna Groom
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Ethan Goddard-Borger
- Associate Professor Gemma Kelly
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor John Wentworth
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Kelly Rogers
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Melissa Call
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Shalin Naik
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Tracy Putoczki
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Belinda Phipson
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gwo Yaw Ho
- Dr Hamish King
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Jim Whittle
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Nadia Davidson
- Dr Nadia Kershaw
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Rory Bowden
- Dr Samir Taoudi
- Dr Sarah Best
- Dr Saskia Freytag
- Dr Shabih Shakeel
- Dr Sheau Wen Lok
- Dr Stephin Vervoort
- Dr Yunshun Chen
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor Daniel Gray
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor James McCarthy
- Professor James Murphy
- Professor Jane Visvader
- Professor Jeanne Tie
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leanne Robinson
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marnie Blewitt
- Professor Matthew Ritchie
- Professor Melanie Bahlo
- Professor Melissa Davis
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Czabotar
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Sandra Nicholson
- Professor Sant-Rayn Pasricha
- Professor Seth Masters
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Papenfuss
- Professor Wai-Hong Tham
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Clinician-scientist training
- Undergraduate
- Student research projects
- A multi-pronged approach to targeting myeloproliferative neoplasms
- A new paradigm of machine learning-based structural variant detection
- A whole lot of junk or a treasure trove of discovery?
- Advanced imaging interrogation of pathogen induced NETosis
- Analysing the metabolic interactions in brain cancer
- Atopic dermatitis causes and treatments
- Boosting the efficacy of immunotherapy in lung cancer
- Building a cell history recorder using synthetic biology for longitudinal patient monitoring
- Characterisation of malaria parasite proteins exported into infected liver cells
- Deciphering the heterogeneity of the tissue microenvironment by multiplexed 3D imaging
- Defining the mechanisms of thymic involution and regeneration
- Delineating the molecular and cellular origins of liver cancer to identify therapeutic targets
- Developing computational methods for spatial transcriptomics data
- Developing drugs to block malaria transmission
- Developing models for prevention of hereditary ovarian cancer
- Developing statistical frameworks for analysing next generation sequencing data
- Development and mechanism of action of novel antimalarials
- Development of novel RNA sequencing protocols for gene expression analysis
- Discoveries in red blood cell production and function
- Discovering epigenetic silencing mechanisms in female stem cells
- Discovery and targeting of novel regulators of transcription
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Dissecting mechanisms of cytokine signalling
- Doublecortin-like kinases, drug targets in cancer and neurological disorders
- Epigenetic biomarkers of tuberculosis infection
- Epigenetics – genome wide multiplexed single-cell CUT&Tag assay development
- Exploiting cell death pathways in regulatory T cells for cancer immunotherapy
- Exploiting the cell death pathway to fight Schistosomiasis
- Finding treatments for chromatin disorders of intellectual disability
- Functional epigenomics in human B cells
- How do nutrition interventions and interruption of malaria infection influence development of immunity in sub-Saharan African children?
- Human lung protective immunity to tuberculosis
- Improving therapy in glioblastoma multiforme by activating complimentary programmed cell death pathways
- Innovating novel diagnostic tools for infectious disease control
- Integrative analysis of single cell RNAseq and ATAC-seq data
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigation of a novel cell death protein
- Malaria: going bananas for sex
- Mapping spatial variation in gene and transcript expression across tissues
- Mechanisms of Wnt secretion and transport
- Multi-modal computational investigation of single-cell communication in metastatic cancer
- Nanoparticle delivery of antibody mRNA into cells to treat liver diseases
- Naturally acquired immune response to malaria parasites
- Organoid-based discovery of new drug combinations for bowel cancer
- Organoid-based precision medicine approaches for oral cancer
- Removal of tissue contaminations from RNA-seq data
- Reversing antimalarial resistance in human malaria parasites
- Role of glycosylation in malaria parasite infection of liver cells, red blood cells and mosquitoes
- Screening for novel genetic causes of primary immunodeficiency
- Single-cell ATAC CRISPR screening – Illuminate chromatin accessibility changes in genome wide CRISPR screens
- Spatial single-cell CRISPR screening – All in one screen: Where? Who? What?
- Statistical analysis of single-cell multi-omics data
- Structural and functional analysis of epigenetic multi-protein complexes in genome regulation
- Structural basing for Wnt acylation
- Structure, dynamics and impact of extra-chromosomal DNA in cancer
- Targeted deletion of disease-causing T cells
- Targeting cell death pathways in tissue Tregs to treat inflammatory diseases
- The cellular and molecular calculation of life and death in lymphocyte regulation
- The role of hypoxia in cell death and inflammation
- The role of ribosylation in co-ordinating cell death and inflammation
- Understanding Plasmodium falciparum invasion of red blood cells
- Understanding cellular-cross talk within a tumour microenvironment
- Understanding the genetics of neutrophil maturation
- Understanding the roles of E3 ubiquitin ligases in health and disease
- Unveiling the heterogeneity of small cell lung cancer
- Using combination immunotherapy to tackle heterogeneous brain tumours
- Using intravital microscopy for immunotherapy against brain tumours
- Using nanobodies to understand malaria invasion and transmission
- Using structural biology to understand programmed cell death
- Validation and application of serological markers of previous exposure to malaria
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Ashley Weir
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jasmine Rou
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Krishneel Prasa
- Lilly Backshell
- Malvika Kharbanda
- Megan Kent
- Naomi Jones
- Pailene Lim
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Sophie Collard
- Wayne Cawthorne
- Wil Lehmann
- Yanxiang Meng
- Zhong Yan Gan
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- Learning Hub
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A generous vision for impactful medical research
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Philanthropy through the power of sisterhood
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- Donors
- WEHI.TV
Dementia

Dementia is a term used to describe chronic and progressive decline in memory and other thinking skills, and the associated impacts on people’s ability to function. It can result from a number of neurodegenerative conditions, the most common being Alzheimer’s disease.
Yassi (R) are developing a blood test to distinguish
between different types of dementia
Dementia is currently incurable, and its underlying cause are challenging to diagnose, particularly at early stages.
In Australia, more than 440,000 people – mostly older individuals – have dementia. It is predicted to soon become the leading cause of death in Australia. This condition also has a huge social and economic burden on our community, with people with dementia being unable to work and requiring ongoing assistance and support.
Our dementia research
We are taking a multi-disciplinary approach to improving the outlook for people with dementia, involving clinicians from different medical disciplines, as well as experts in proteomics, cell biology and drug discovery.
Specific areas of focus for our dementia research are:
- Understanding and detecting the brain changes that occur in the early stages of dementia, to develop new diagnostic tests, that could allow people to access the best available treatments sooner.
- Discovering new genetic clues behind the different causes of dementia and other neurodegenerative disorders.
- Supporting collaborative and multidisciplinary clinical cohorts in dementia to understand and untangle the overlap of the different causes of dementia
- Using knowledge of the causes to discover new medicines that could potentially halt or even reverse the progression of dementia and conditions that lead to dementia, including Parkinson’s disease.
- Leading investigator-initiated clinical trials to test new potential therapies for dementia.
Our dementia research has been boosted by the establishment of the Colonial Foundation Healthy Ageing Centre, a collaboration with The Royal Melbourne Hospital.
What is dementia?
People with dementia experience changes in their thinking, memory and behaviour. These can include:
- memory loss and confusion
- a decrease in language skills
- personality changes
- an inability to perform everyday tasks such as preparing meals or dressing.
Symptoms of dementia can vary between patients, and with different types of dementia.
The most common forms of dementia in Australia are Alzheimer’s disease, dementia with Lewy Bodies and vascular dementia. Dementia can also occur as a result of other neurodegenerative conditions such as Parkinson’s disease and motor neurone disease.
Dementia risk factors
- Age: the risk of developing dementia increases with age.
- Family history and genetics: people with close relatives with dementia are more likely to develop the condition themselves. In a few cases, specific genetic changes have been associated with an increased risk of dementia.
- Moderate to severe or repetitive head injuries may increase a person’s risk of developing dementia.
- A range of other health conditions can increase a person’s risk of dementia. These include depression, vascular diseases such as high blood pressure, obesity and type 2 diabetes.
How is dementia diagnosed and treated?
Dementia can be difficult to diagnose, particularly at earlier stages. Most dementia types also have a long preclinical phase where there is accumulation of changes in the brain with little or no symptoms. This is challenging as any potential disease-modifying therapies are most likely to be effective if delivered early in the disease. Early diagnosis also enables a person with dementia to be involved in planning their future care.
Colonial Foundation Healthy Ageing Centre, which
aims to develop diagnostic tests for the early detection
of dementia
There is no single diagnostic test for any form of dementia. Diagnosing dementia requires consideration of a person’s family and medical history and testing of thinking and memory abilities. Changes to the person’s behaviour or personality are also considered when diagnosing dementia. In some people with dementia, changes in their brain’s structure can be seen using medical imaging. Symptoms of dementia overlap with other conditions such as nutrient deficiencies, depression or medication side-effects, and these need to be excluded as part of the diagnosis.
There is a potential for specific diagnostic biomarkers to help in the diagnosis of dementia and its different causes. Most research in this area has been in the field of Alzheimer’s disease, where measurement of Alzheimer’s disease pathology using medical imaging (PET) or spinal fluid analysis can identify the underlying disease process and can complement clinical assessment. However, these tools are not routinely available in the clinic and are largely research-based tools due to their cost, difficulty of access, and invasiveness. Many groups are currently actively investigating the potential for a blood test to measure these changes quickly, accurately and non-invasively which would revolutionise dementia diagnosis.
There are medications that help treat the symptoms in some forms of dementia, but they do not cure this condition. People with early-stage dementia may choose to plan for their future requirements such as selecting future forms of assistance and deciding on their living arrangements. Occupational therapy can help people with dementia adjust their environment to meet their changing needs, and improve their safety. Exercise may also help to slow cognitive decline in certain forms of dementia. Close friends and family members can also be educated about effective ways to assist and communicate with people with dementia.
Support for people impacted by dementia
Our researchers are not able to provide specific medical advice to individuals. If you have been diagnosed with dementia or are supporting someone with this condition, please visit:
Researchers:
Super Content:
Learn about our research into the causes of neurodegenerative disorders, and our work to develop new treatments for these conditions.
The grant will enable a new research program – led by researchers at the Walter and Eliza Hall Institute and The Royal Melbourne Hospital – to develop diagnostic tests for the early detection of dementia in people as young as 40.
Our scientists are working to improve the detection of neurodegenerative conditions that cause dementia.
Our researchers have revealed how a key protein protects against the death of neurons that occurs in Parkinson's disease.
Associate Professor Rosie Watson describes her work to develop a blood test to improve the clinical diagnosis of dementia.
WEHI’s Associate Professor Andrew Webb and the Royal Melbourne Hospital’s Associate Professor Cherie Chiang are developing an early diagnosis test for dementia at the Colonial Foundation Healthy Ageing Centre.